{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:40:19Z","timestamp":1773920419835,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["SCR_022889"],"award-info":[{"award-number":["SCR_022889"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006686","name":"University of Miami","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006686","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA249949"],"award-info":[{"award-number":["R01CA249949"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018896","name":"Sylvester Comprehensive Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018896","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.neo.2025.101257","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T10:11:40Z","timestamp":1763892700000},"page":"101257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Enhancing the antitumor efficacy using a combination of FGFR4 Inhibitor (H3B-6527) and oxaliplatin in gastric cancer"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9776-0193","authenticated-orcid":false,"given":"Nadeem","family":"Bhat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5597-4588","authenticated-orcid":false,"given":"Mohammed","family":"Soutto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwah","family":"Al-Mathkour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Silvia Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Chwihne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1108-2449","authenticated-orcid":false,"given":"Melanie","family":"Genoula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah","family":"Ballout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6907-2916","authenticated-orcid":false,"given":"Shoumin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver G","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2101-6098","authenticated-orcid":false,"given":"Wael","family":"El-Rifai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2025.101257_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.neo.2025.101257_bib0002","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.neo.2025.101257_bib0003","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics","volume":"75","author":"Siegel","year":"2025","journal-title":"Ca-Cancer J. Clin."},{"key":"10.1016\/j.neo.2025.101257_bib0004","series-title":"Surveillance Research Program NCI","year":"2024"},{"key":"10.1016\/j.neo.2025.101257_bib0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-023-01761-7","article-title":"Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF\/FGFR signaling in tumor microenvironment","volume":"22","author":"Ruan","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.neo.2025.101257_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102998","article-title":"Fibroblast growth factor receptor-4 mediates activation of Nuclear Factor Erythroid 2-Related Factor-2 in gastric tumorigenesis","volume":"69","author":"Soutto","year":"2024","journal-title":"Redox. Biol."},{"key":"10.1016\/j.neo.2025.101257_bib0007","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1053\/j.gastro.2022.05.016","article-title":"Induction of fibroblast growth factor receptor 4 by Helicobacter pylori via signal transducer and activator of transcription 3 with a feedforward activation loop involving SRC signaling in gastric cancer","volume":"163","author":"Zhang","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neo.2025.101257_bib0008","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fcell.2020.00095","article-title":"Dissecting the role of the FGF19-FGFR4 signaling pathway in cancer development and progression","volume":"8","author":"Liu","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.neo.2025.101257_bib0009","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41416-024-02658-y","article-title":"FGFR4-driven plasticity in breast cancer progression and resistance to therapy","volume":"131","author":"Braun","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.neo.2025.101257_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115947","article-title":"Insight into the design of FGFR4 selective inhibitors in cancer therapy: prospects and challenges","volume":"263","author":"Chen","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neo.2025.101257_bib0011","first-page":"2733","article-title":"Combined inhibition of FGFR4 and VEGFR signaling enhances efficacy in FGF19 driven hepatocellular carcinoma","volume":"12","author":"Zhao","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.neo.2025.101257_bib0012","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12876-025-03624-5","article-title":"Capecitabine enhances sensitivity to oxaliplatin in advanced gastric cancer and the effects on patients' FOXP1 and GGT levels","volume":"25","author":"Guo","year":"2025","journal-title":"BMC. Gastroenterol."},{"key":"10.1016\/j.neo.2025.101257_bib0013","article-title":"Oxaliplatin and its derivatives\u2013an overview","volume":"497","author":"O\u2019Dowd","year":"2023","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.neo.2025.101257_bib0014","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3892\/ol.2021.13124","article-title":"Establishment and characterization of prostate organoids from treatment-naive patients with prostate cancer","volume":"23","author":"Cheaito","year":"2022","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.neo.2025.101257_bib0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/9780470942390.mo130179","article-title":"Establishment of gastrointestinal epithelial organoids","volume":"3","author":"Mahe","year":"2013","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"10.1016\/j.neo.2025.101257_bib0016","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1158\/0008-5472.CAN-19-1166","article-title":"A comprehensive PDX gastric cancer collection captures cancer cell-intrinsic transcriptional MSI traits","volume":"79","author":"Corso","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2025.101257_bib0017","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s13046-022-02472-5","article-title":"APE1 redox function is required for activation of Yes-associated protein 1 under reflux conditions in Barrett's-associated esophageal adenocarcinomas","volume":"41","author":"Ballout","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.neo.2025.101257_bib0018","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13045-024-01558-1","article-title":"Targeting FGFR for cancer therapy","volume":"17","author":"Zhang","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.neo.2025.101257_bib0019","doi-asserted-by":"crossref","first-page":"6999","DOI":"10.1158\/0008-5472.CAN-17-1865","article-title":"H3B-6527 Is a potent and selective inhibitor of FGFR4 in FGF19-driven hepatocellular carcinoma","volume":"77","author":"Joshi","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2025.101257_bib0020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s12072-025-10788-5","article-title":"Cancer-associated fibroblasts in hepatocellular carcinoma: heterogeneity, mechanisms and therapeutic targets","volume":"19","author":"Li","year":"2025","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.neo.2025.101257_bib0021","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2208844119","article-title":"FGFR redundancy limits the efficacy of FGFR4-selective inhibitors in hepatocellular carcinoma","volume":"119","author":"Tao","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U S. A"},{"key":"10.1016\/j.neo.2025.101257_bib0022","doi-asserted-by":"crossref","first-page":"e1046","DOI":"10.1038\/cddis.2014.10","article-title":"Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer","volume":"5","author":"Turkington","year":"2014","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.neo.2025.101257_bib0023","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13046-024-02949-5","article-title":"Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery","volume":"43","author":"Hu","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.neo.2025.101257_bib0024","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41568-018-0090-8","article-title":"Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map","volume":"19","author":"Huynh","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neo.2025.101257_bib0025","first-page":"19","article-title":"Bcl-2 inhibition to overcome resistance to chemo- and immunotherapy","author":"Garcia-Aranda","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neo.2025.101257_bib0026","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/(SICI)1097-4644(19960101)60:1<23::AID-JCB5>3.0.CO;2-5","article-title":"BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy","volume":"60","author":"Reed","year":"1996","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.neo.2025.101257_bib0027","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41573-022-00615-z","article-title":"Rational combinations of targeted cancer therapies: background, advances and challenges","volume":"22","author":"Jin","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neo.2025.101257_bib0028","first-page":"12","article-title":"FGFR4 Inhibitor BLU9931 attenuates pancreatic cancer cell proliferation and invasion while inducing senescence: evidence for senolytic therapy potential in pancreatic cancer","author":"Sasaki","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.neo.2025.101257_bib0029","first-page":"24","article-title":"Overcoming acquired drug resistance to cancer therapies through targeted STAT3 inhibition","author":"Singh","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neo.2025.101257_bib0030","first-page":"15","article-title":"Combining STAT3-targeting agents with Immune checkpoint inhibitors in NSCLC","author":"Papavassiliou","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.neo.2025.101257_bib0031","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jhep.2008.08.015","article-title":"Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention","volume":"50","author":"Ho","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.neo.2025.101257_bib0032","first-page":"5304","article-title":"Fibroblast growth factor receptor 4 regulates proliferation and antiapoptosis during gastric cancer progression","volume":"117","author":"Ye","year":"2011","journal-title":"Cancer-Am. Cancer Soc."},{"key":"10.1016\/j.neo.2025.101257_bib0033","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000489759","article-title":"FGFR4 Links glucose metabolism and chemotherapy resistance in breast cancer","volume":"47","author":"Xu","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.neo.2025.101257_bib0034","doi-asserted-by":"crossref","DOI":"10.1007\/s10120-025-01596-9","article-title":"Lenvatinib suppress FGF19-FGFR4 signaling to enhance antitumor immune response in gastric cancer","author":"Maruyama","year":"2025","journal-title":"Gastric. Cancer"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625001368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625001368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:55:33Z","timestamp":1773903333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558625001368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":34,"alternative-id":["S1476558625001368"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2025.101257","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing the antitumor efficacy using a combination of FGFR4 Inhibitor (H3B-6527) and oxaliplatin in gastric cancer","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2025.101257","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101257"}}